Replies to post #83843 on Biotech Values

[InTheTrenches]

I thought the report understated potential sales of M-118, as well.

Given it's advantages, wouldn't M-118 mostly replace Lovenox in ACS?

[mouton29]

MNTA: << One would be left with the impression that a competitor of Momenta may have ghost-written the thing!>>

I don't know about that, but is the following usual for Deutsche Bank reports?

Deutsche Bank Securities Inc. Page 39
The author of this report, Robyn Karnauskas, wishes to acknowledge the contributions made by Mohit Bansal, employee of
Irevna, a division of CRISIL Limited, a third party provider of offshore research support services to Deutsche Bank

I did note what seemed me an unusual number of typos -- affect for effect, precedence for precedent and several sentences with missing or extra words.